- Home
- ELTX vs GNTA Comparison
ELTX vs GNTA Comparison
Compare ELTX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELTX | GNTA |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 41.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELTX | GNTA |
|---|---|---|
| Price | $8.16 | $1.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 108.0K | 106.2K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.60 | $1.35 |
| 52 Week High | $12.62 | $10.00 |
Technical Indicators
Market Signals| Indicator | ELTX | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 30.36 |
| Support Level | $7.90 | $1.80 |
| Resistance Level | $9.00 | $2.07 |
| Average True Range (ATR) | 0.62 | 0.18 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 36.32 | 0.00 |
Price Performance
Historical ComparisonAbout ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.